Cargando…

Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea

We conducted a heterogeneous risk assessment of breast cancer based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) calculating the risks and population-based attributable fractions (PAFs) for modifiable and nonmodifiable factors. Using matched case–control study des...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Boyoung, Choi, Ji-Yeob, Sung, Ho Kyung, Ahn, Choonghyun, Hwang, Yunji, Jang, Jieun, Lee, Juyeon, Kim, Heewon, Shin, Hai-Rim, Park, Sohee, Han, Wonshik, Noh, Dong-Young, Yoo, Keun-Young, Kang, Daehee, Park, Sue K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998747/
https://www.ncbi.nlm.nih.gov/pubmed/27057831
http://dx.doi.org/10.1097/MD.0000000000003063
_version_ 1782449997588987904
author Park, Boyoung
Choi, Ji-Yeob
Sung, Ho Kyung
Ahn, Choonghyun
Hwang, Yunji
Jang, Jieun
Lee, Juyeon
Kim, Heewon
Shin, Hai-Rim
Park, Sohee
Han, Wonshik
Noh, Dong-Young
Yoo, Keun-Young
Kang, Daehee
Park, Sue K.
author_facet Park, Boyoung
Choi, Ji-Yeob
Sung, Ho Kyung
Ahn, Choonghyun
Hwang, Yunji
Jang, Jieun
Lee, Juyeon
Kim, Heewon
Shin, Hai-Rim
Park, Sohee
Han, Wonshik
Noh, Dong-Young
Yoo, Keun-Young
Kang, Daehee
Park, Sue K.
author_sort Park, Boyoung
collection PubMed
description We conducted a heterogeneous risk assessment of breast cancer based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) calculating the risks and population-based attributable fractions (PAFs) for modifiable and nonmodifiable factors. Using matched case–control study design from the Seoul Breast Cancer Study and the national prevalence of exposure, the risks and PAFs for modifiable and nonmodifiable factors were estimated for total breast cancers and subtypes. The attribution to modifiable factors was different for each subtype (luminal A, PAF = 61.4% [95% confidence interval, CI = 54.3%–69.8%]; luminal B, 21.4% [95% CI = 18.6–24.9%]; HER2-overexpression, 59.4% [95% CI = 47.8%–74.3%], and triple negative tumors [TNs], 27.1% [95% CI = 22.9%–32.4%)], and the attribution to the modifiable factors for the luminal A and HER2-overexpression subtypes was higher than that of the luminal B and TN subtypes (P heterogeneity ≤ 0.001). The contribution of modifiable reproductive factors to luminal A type in premenopausal women was higher than that of the other subtypes (18.2% for luminal A; 3.1%, 8.1%, and −3.1% for luminal B, HER2-overexpression, and TN subtypes, respectively; P heterogeneity ≤ 0.001). Physical activity had the highest impact preventing 32.6% of luminal A, 14.5% of luminal B, 38.0% of HER2-overexpression, and 26.9% of TN subtypes (P heterogeneity = 0.014). Total reproductive factors were also heterogeneously attributed to each breast cancer subtype (luminal A, 65.4%; luminal B, 24.1%; HER2-overexpression, 57.9%, and TN subtypes, −3.1%; P heterogeneity ≤ 0.001). Each pathological subtype of breast cancer by HRs and HER2 status may be associated with heterogeneous risk factors and their attributable risk, suggesting a different etiology. The luminal B and TN subtypes seemed to be less preventable despite intervention for alleged risk factors, even though physical activity had a high preventable potential against breast cancer.
format Online
Article
Text
id pubmed-4998747
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49987472016-08-29 Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea Park, Boyoung Choi, Ji-Yeob Sung, Ho Kyung Ahn, Choonghyun Hwang, Yunji Jang, Jieun Lee, Juyeon Kim, Heewon Shin, Hai-Rim Park, Sohee Han, Wonshik Noh, Dong-Young Yoo, Keun-Young Kang, Daehee Park, Sue K. Medicine (Baltimore) 4400 We conducted a heterogeneous risk assessment of breast cancer based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) calculating the risks and population-based attributable fractions (PAFs) for modifiable and nonmodifiable factors. Using matched case–control study design from the Seoul Breast Cancer Study and the national prevalence of exposure, the risks and PAFs for modifiable and nonmodifiable factors were estimated for total breast cancers and subtypes. The attribution to modifiable factors was different for each subtype (luminal A, PAF = 61.4% [95% confidence interval, CI = 54.3%–69.8%]; luminal B, 21.4% [95% CI = 18.6–24.9%]; HER2-overexpression, 59.4% [95% CI = 47.8%–74.3%], and triple negative tumors [TNs], 27.1% [95% CI = 22.9%–32.4%)], and the attribution to the modifiable factors for the luminal A and HER2-overexpression subtypes was higher than that of the luminal B and TN subtypes (P heterogeneity ≤ 0.001). The contribution of modifiable reproductive factors to luminal A type in premenopausal women was higher than that of the other subtypes (18.2% for luminal A; 3.1%, 8.1%, and −3.1% for luminal B, HER2-overexpression, and TN subtypes, respectively; P heterogeneity ≤ 0.001). Physical activity had the highest impact preventing 32.6% of luminal A, 14.5% of luminal B, 38.0% of HER2-overexpression, and 26.9% of TN subtypes (P heterogeneity = 0.014). Total reproductive factors were also heterogeneously attributed to each breast cancer subtype (luminal A, 65.4%; luminal B, 24.1%; HER2-overexpression, 57.9%, and TN subtypes, −3.1%; P heterogeneity ≤ 0.001). Each pathological subtype of breast cancer by HRs and HER2 status may be associated with heterogeneous risk factors and their attributable risk, suggesting a different etiology. The luminal B and TN subtypes seemed to be less preventable despite intervention for alleged risk factors, even though physical activity had a high preventable potential against breast cancer. Wolters Kluwer Health 2016-04-08 /pmc/articles/PMC4998747/ /pubmed/27057831 http://dx.doi.org/10.1097/MD.0000000000003063 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial License, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 4400
Park, Boyoung
Choi, Ji-Yeob
Sung, Ho Kyung
Ahn, Choonghyun
Hwang, Yunji
Jang, Jieun
Lee, Juyeon
Kim, Heewon
Shin, Hai-Rim
Park, Sohee
Han, Wonshik
Noh, Dong-Young
Yoo, Keun-Young
Kang, Daehee
Park, Sue K.
Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
title Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
title_full Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
title_fullStr Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
title_full_unstemmed Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
title_short Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
title_sort attribution to heterogeneous risk factors for breast cancer subtypes based on hormone receptor and human epidermal growth factor 2 receptor expression in korea
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998747/
https://www.ncbi.nlm.nih.gov/pubmed/27057831
http://dx.doi.org/10.1097/MD.0000000000003063
work_keys_str_mv AT parkboyoung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT choijiyeob attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT sunghokyung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT ahnchoonghyun attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT hwangyunji attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT jangjieun attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT leejuyeon attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT kimheewon attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT shinhairim attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT parksohee attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT hanwonshik attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT nohdongyoung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT yookeunyoung attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT kangdaehee attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea
AT parksuek attributiontoheterogeneousriskfactorsforbreastcancersubtypesbasedonhormonereceptorandhumanepidermalgrowthfactor2receptorexpressioninkorea